These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21071459)

  • 21. [Antitubercular effect of capreomycin in vitro].
    Janowiec M
    Gruzlica; 1969 Jul; 37(7):629-35. PubMed ID: 4981783
    [No Abstract]   [Full Text] [Related]  

  • 22. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
    Taneja NK; Tyagi JS
    J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
    Martins M; Viveiros M; Ramos J; Couto I; Molnar J; Boeree M; Amaral L
    Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility testing of Mycobacterium tuberculosis by broth microdilution method: a rapid alternative method.
    Sethi S; Mandal J; Kumar P; Kumar S; Meharwal S; Jindal SK; Sharma M
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):447-9. PubMed ID: 17141450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determination of the bactericidal power of liquid Borex against m. tuberculosis. In vitro experiments and biologic tests].
    Branchini C; Ossido G
    Rass Int Stomatol Prat; 1968; 19(1):61-6. PubMed ID: 4969928
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
    Ausina Ruiz V; Lonca Giménez J
    Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 28. Secondary anti-tuberculosis drugs. II: resistant typical mycobacterium tuberculosis, unclassified mycobacteria.
    J Kans Med Soc; 1968 Nov; 69(11):534-6 concl. PubMed ID: 4972834
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and antitubercular activity of novel Schiff bases derived from d-mannitol.
    Ferreira Mde L; Vasconcelos TR; de Carvalho EM; Lourenço MC; Wardell SM; Wardell JL; Ferreira VF; de Souza MV
    Carbohydr Res; 2009 Oct; 344(15):2042-7. PubMed ID: 19709650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.
    de Steenwinkel JE; de Knegt GJ; ten Kate MT; van Belkum A; Verbrugh HA; Kremer K; van Soolingen D; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2010 Dec; 65(12):2582-9. PubMed ID: 20947621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determining dehydrogenase activity as a method of accelerated indication of the viability of Mycobacterium tuberculosis].
    Vishnevskiĭ BI; Manicheva OA
    Probl Tuberk; 1992; (7-8):42-4. PubMed ID: 1488441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mechanism of action "in vitro" and "in vivo" of antitubercular drugs].
    Gialdroni-Grassi G
    G Ital Chemioter; 1966; 13(1):11-26. PubMed ID: 4967319
    [No Abstract]   [Full Text] [Related]  

  • 33. [Short term chemotherapy of tuberculosis. Bactericidal mechanisms in short term chemotherapy].
    Mitchison DA; Dickinson JM
    Bull Int Union Tuberc; 1978 Dec; 53(4):270-5. PubMed ID: 115526
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 35. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis.
    Bapela NB; Lall N; Fourie PB; Franzblau SG; Van Rensburg CE
    Phytomedicine; 2006 Nov; 13(9-10):630-5. PubMed ID: 16987644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
    Early JV; Mullen S; Parish T
    PLoS One; 2019; 14(10):e0222970. PubMed ID: 31589621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
    Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies of the early bactericidal activity of new drugs for tuberculosis: a help or a hindrance to antituberculosis drug development?
    O'Brien RJ
    Am J Respir Crit Care Med; 2002 Jul; 166(1):3-4. PubMed ID: 12091159
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
    Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
    Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.